Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models

Neoplasia - Tập 18 - Trang 775-784 - 2016
Jose F. Ponte1, Olga Ab1, Leanne Lanieri1, Jenny Lee1, Jennifer Coccia1, Laura M. Bartle1, Marian Themeles1, Yinghui Zhou1, Jan Pinkas1, Rodrigo Ruiz-Soto1
1ImmunoGen, Inc., Waltham, MA, USA

Tài liệu tham khảo